HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Huijuan Shi Selected Research

Investigational Therapies (Experimental Therapy)

7/2022Self-Assembly of a Multifunction DNA Tetrahedron for Effective Delivery of Aptamer PL1 and Pcsk9 siRNA Potentiate Immune Checkpoint Therapy for Colorectal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Huijuan Shi Research Topics

Disease

30Neoplasms (Cancer)
03/2024 - 07/2012
9Neoplasm Metastasis (Metastasis)
03/2024 - 01/2011
8Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 08/2013
8Carcinogenesis
01/2021 - 07/2012
6Breast Neoplasms (Breast Cancer)
10/2023 - 01/2018
6Psoriasis (Pustulosis Palmaris et Plantaris)
05/2023 - 06/2017
6Infertility (Sterility)
01/2023 - 09/2012
5Colonic Neoplasms (Colon Cancer)
01/2020 - 01/2013
4Stomach Neoplasms (Stomach Cancer)
12/2023 - 07/2015
4Inflammation (Inflammations)
01/2023 - 04/2013
4Male Infertility (Male Sterility)
01/2023 - 02/2015
3Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 09/2015
3Carcinoma (Carcinomatosis)
07/2022 - 01/2014
3Ewing Sarcoma (Sarcoma, Ewing)
01/2021 - 11/2013
3Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 01/2016
2Hyperthermia
12/2023 - 01/2021
2Pruritus (Itching)
05/2023 - 01/2020
2Lung Injury
11/2022 - 01/2018
2Hypogonadism (Hypergonadotropic Hypogonadism)
06/2021 - 01/2021
2Acute Lung Injury
01/2018 - 01/2018
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
07/2015 - 07/2010
2Septic Shock (Toxic Shock Syndrome)
07/2015 - 04/2013
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014 - 09/2014
2Uterine Cervical Dysplasia
10/2014 - 09/2014
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
03/2024
1Adenocarcinoma
03/2024
1Cholangiocarcinoma
03/2024
1Inflammatory Breast Neoplasms
03/2024
1Triple Negative Breast Neoplasms
10/2023
1Erythema
01/2023
1Keratosis
01/2023
1Neuroinflammatory Diseases
01/2023
1Cardiovascular Diseases (Cardiovascular Disease)
01/2023
1Atherosclerosis
01/2023
1Postoperative Cognitive Complications
11/2022
1Brain Death (Brain Dead)
11/2022
1Hypoxia (Hypoxemia)
11/2022
1Inborn Genetic Diseases (Disease, Hereditary)
06/2022
1Androgen-Insensitivity Syndrome (Testicular Feminization)
06/2022
1Disorders of Sex Development (Intersexuality)
06/2022
1Lung Diseases (Lung Disease)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
06/2021

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
01/2023 - 09/2012
8CateninsIBA
01/2018 - 01/2013
6MicroRNAs (MicroRNA)IBA
06/2021 - 10/2014
5Biomarkers (Surrogate Marker)IBA
03/2024 - 02/2016
4Long Noncoding RNAIBA
10/2021 - 01/2018
4hepatoma-derived growth factorIBA
01/2021 - 11/2013
3RNA (Ribonucleic Acid)IBA
03/2024 - 01/2019
3oxymatrineIBA
01/2023 - 06/2017
3Messenger RNA (mRNA)IBA
01/2021 - 11/2013
3qigesanIBA
01/2020 - 01/2016
2Interleukin-10 (Interleukin 10)IBA
01/2023 - 12/2012
2Caspase 3 (Caspase-3)IBA
11/2022 - 04/2017
2human MIRN520 microRNAIBA
09/2022 - 06/2020
2Small Interfering RNA (siRNA)IBA
07/2022 - 07/2012
2Androgen Receptors (Androgen Receptor)IBA
06/2022 - 01/2021
2Circular RNAIBA
01/2022 - 06/2020
2Therapeutic UsesIBA
01/2021 - 04/2013
2EnzymesIBA
01/2020 - 12/2012
2Eosine Yellowish-(YS) (Eosin)IBA
01/2018 - 12/2012
2Beclin-1IBA
04/2016 - 09/2015
2VimentinIBA
01/2015 - 01/2014
2S100 Proteins (S 100 Protein)IBA
01/2014 - 01/2014
2MART-1 AntigenIBA
01/2014 - 01/2014
1CytokinesIBA
03/2024
1pleiotrophin (HARP)IBA
03/2024
1Phenobarbital (Luminal)FDA Link
03/2024
1LipidsIBA
10/2023
1oxidized low density lipoproteinIBA
10/2023
1Apolipoproteins B (ApoB)IBA
10/2023
1TRPV Cation ChannelsIBA
05/2023
1Nerve Growth Factor (NGF)IBA
05/2023
1Immunoconjugates (Immunoconjugate)IBA
02/2023
1trastuzumab deruxtecanIBA
02/2023
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2023
117- hydroxy- 4,7,10,13,15,19- docosahexaenoic acidIBA
01/2023
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2023
19-deoxy-delta-9-prostaglandin D2IBA
01/2023
1Endothelial Growth FactorsIBA
01/2023
1Alkaline PhosphataseIBA
11/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2022
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2022
1Proteasome InhibitorsIBA
11/2022
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
11/2022
1Granzymes (Granzyme)IBA
07/2022
1DNA (Deoxyribonucleic Acid)IBA
07/2022
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2022
1Biocompatible Materials (Biomaterials)IBA
07/2022
1Paclitaxel (Taxol)FDA LinkGeneric
10/2021
1Competitive Endogenous RNAIBA
06/2021

Therapy/Procedure

9Therapeutics
03/2024 - 01/2013
3Drug Therapy (Chemotherapy)
01/2020 - 01/2013
3Radiotherapy
01/2020 - 01/2011
2Neoadjuvant Therapy
02/2023 - 01/2021
2Aftercare (After-Treatment)
01/2022 - 11/2014
2Hyperthermic Intraperitoneal Chemotherapy
01/2021 - 07/2015
1Immunomodulation
12/2023
1General Anesthesia
11/2022
1Investigational Therapies (Experimental Therapy)
07/2022